Over the last few years there has been a growing interest in the impact of sex and gender on health and health care. Policy makers and practitioners are being asked to make their services more "gender sensitive" while researchers are being called upon to pay equal attention to the needs of women and men. This editorial offers a brief introduction to some of the challenges that will need to be met if an appropriate evidence base for this more equitable approach to health care is to be achieved. The first challenge is a conceptual one. There continues to be a lack of clarity among biomedical researchers about the distinction between sex and gender. Too often the two are used interchangeably. However in the correct usage, the term "sex" refers to the biological differences between women and men while the term "gender" refers to the social differences (Doyal 2001) . Unless this distinction is clearly understood it will be hard for researchers to make proper sense of any observed differences between women and men or to plan appropriate interventions. (Kahn et al. 1998) .This has been especially evident in the area of heart disease. In developed countries this is the single most important cause of death in women over 55. Yet many of the major studies that provide the knowledge base for their treatment were based on all-male samples (Mastroianni et al. 1994) . In response to evidence of this bias, the U. S. government passed a number of measures designed to "mainstream" sex and gender issues in medical research (Mastroianni et al. 1994 (Krieger 2000) . It is clear that in the coming decades some of the most exciting work in health research will be interdisciplinary in approach and those already involved in social and preventive medicine are well placed to contribute to these developments.
But it is not enough to recognise the distinction between biological sex and social gender as determinants of health. Researchers must also face a second challenge of how to integrate these very different factors into the design of their studies. Concerns of this kind have received particular attention in the U. S. where commentators have highlighted the male bias in both epidemiological research and clinical trials

